Skip to content
10-K

Annual Report

Vanda Pharmaceuticals Inc. VNDA

0001628280-26-007460

← back to feed
Filed
Feb 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 5, 2026 59.11M sh
Shares Diluted FY 2025 · Dec 31, 2025 58.93M sh
Shares Diluted FY 2025 · Dec 31, 2024 58.15M sh
Shares Diluted FY 2025 · Dec 31, 2023 57.56M sh
Capex FY 2025 · Dec 31, 2025 $998K
Capex FY 2025 · Dec 31, 2024 $490K
Capex FY 2025 · Dec 31, 2023 $383K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$109.44M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$15.76M
Operating Cash Flow FY 2025 · Dec 31, 2023 $12.8M
Cash And Equivalents FY 2025 · Dec 31, 2025 $84.85M
Cash And Equivalents FY 2025 · Dec 31, 2024 $102.32M
Stockholders Equity FY 2025 · Dec 31, 2025 $327.19M
Stockholders Equity FY 2025 · Dec 31, 2024 $538.55M
Stockholders Equity FY 2025 · Dec 31, 2023 $544.91M
Stockholders Equity FY 2025 · Dec 31, 2022 $527.2M
Current Liabilities FY 2025 · Dec 31, 2025 $145.16M
Current Liabilities FY 2025 · Dec 31, 2024 $99.98M
Total Liabilities FY 2025 · Dec 31, 2025 $161.76M
Total Liabilities FY 2025 · Dec 31, 2024 $117.66M
Current Assets FY 2025 · Dec 31, 2025 $347.26M
Current Assets FY 2025 · Dec 31, 2024 $438.89M
Total Assets FY 2025 · Dec 31, 2025 $488.95M
Total Assets FY 2025 · Dec 31, 2024 $656.2M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.74
Eps Diluted FY 2025 · Dec 31, 2024 −$0.33
Eps Diluted FY 2025 · Dec 31, 2023 $0.04
Eps Basic FY 2025 · Dec 31, 2025 −$3.74
Eps Basic FY 2025 · Dec 31, 2024 −$0.33
Eps Basic FY 2025 · Dec 31, 2023 $0.04
Sga Expense FY 2025 · Dec 31, 2025 $237.95M
Sga Expense FY 2025 · Dec 31, 2024 $146.41M
Sga Expense FY 2025 · Dec 31, 2023 $112.88M
Rd Expense FY 2025 · Dec 31, 2025 $109.27M
Rd Expense FY 2025 · Dec 31, 2024 $74.43M
Rd Expense FY 2025 · Dec 31, 2023 $76.82M
Net Income FY 2025 · Dec 31, 2025 −$220.47M
Net Income FY 2025 · Dec 31, 2024 −$18.9M
Net Income FY 2025 · Dec 31, 2023 $2.51M
Operating Income FY 2025 · Dec 31, 2025 −$151.17M
Operating Income FY 2025 · Dec 31, 2024 −$40.66M
Operating Income FY 2025 · Dec 31, 2023 −$13.95M
Revenue FY 2025 · Dec 31, 2025 $216.11M
Revenue FY 2025 · Dec 31, 2024 $198.77M
Revenue FY 2025 · Dec 31, 2023 $192.64M